Nelfinavir: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nelfinavir. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Diarrhea | 20% |
| Nausea | 7% |
| Flatulence | 5% |
| Rash | 3% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV infection.
Source: FDA labeling via NIH DailyMed (set 9b370904…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.